Cargando…
Clinical and Immunological Effects of p53-Targeting Vaccines
Immunotherapy, including immune checkpoint blockade and chimeric antigen receptor T cells, is one of the most promising approaches to treat cancer. Vaccines have been effective in preventing cancers like liver cancer and cervical cancer with a viral etiology. Instead of preventing disease, therapeut...
Autores principales: | Zhou, Shan, Fan, Chunmei, Zeng, Zhaoyang, Young, Ken H., Li, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595300/ https://www.ncbi.nlm.nih.gov/pubmed/34805170 http://dx.doi.org/10.3389/fcell.2021.762796 |
Ejemplares similares
-
Corrigendum: Clinical and immunological effects of p53-targeting vaccines
por: Zhou, Shan, et al.
Publicado: (2023) -
Identification of Potential Antigens for Developing mRNA Vaccine for Immunologically Cold Mesothelioma
por: Zhang, Shichao, et al.
Publicado: (2022) -
p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets
por: Rahman, Md Ataur, et al.
Publicado: (2022) -
Hesperidin Ameliorates Dexamethasone-Induced Osteoporosis by Inhibiting p53
por: Zhang, Meng, et al.
Publicado: (2022) -
p63 and p53: Collaborative Partners or Dueling Rivals?
por: Woodstock, Dana L., et al.
Publicado: (2021)